Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
PCSK9
Pharma
Amgen's Repatha meets the mark in CV primary prevention trial
On the heels of a label expansion in August, Amgen is touting another potential avenue to extend the value of its aging PCSK9 cholesterol med Repatha.
Fraiser Kansteiner
Oct 2, 2025 11:26am
Sanofi, Trump, VC capital crunch—Fierce Pharma Asia
Aug 8, 2025 9:32am
Carvykti, Sangon, China and more—Fierce Pharma Asia
Aug 18, 2023 9:10am
Sanofi, Regeneron clinch win in PCSK9 patent feud with Amgen
May 18, 2023 3:16pm
Samsung, Olympus, Dr. Reddy's—Fierce Pharma Asia
Mar 3, 2023 9:45am
Amgen garners wide support in SCOTUS patent fight with Sanofi
Jan 4, 2023 11:38am
